Slide locked Sign in to view
Slide schematic 6/7
list 3/3 metric 0/1 source-note 1/1 title 2/2
1 without position metric 1
metric · primary
Components 7
bullet bullet bullet primary source-note action-title headline
Tools 0
No tools

No canon tool match is anchored to this slide.

Metrics 1
adoption rate share_penetration · 65%

The widespread adoption of a new class of drugs for preventing stroke is limited despite clinical and cost-effective benefits

Frameworks 0
No frameworks

No framework match is anchored to this slide.